Politico E&E NEWS, April 18, 2024: EPA released its 2024 report on artificial turf, which says it contains dangerous chemicals but that the exposures are “generally safe.’ NCHR’s Dr. Diana Zuckerman asks what does that mean? If it is generally safe that means it isn’t safe for everyone, but EPA doesn’t explain how many will be harmed and doesn’t explain what is known and not known. It’s not credible.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
Americans Are Paying Billions to Take Drugs That Don’t Work
Bloomberg, April 15, 2024: Since 2014, pharmaceutical companies have made over $3.6 billion from FDA-approved drugs that were later withdrawn or proven ineffective. This news article explores how fast-track approvals may prioritize speed over efficacy, wasting your money and not helping you fight serious diseases.
Read More »10 doctors on FDA panel for Abbott heart device had financial ties to the company. The FDA didn’t disclose the payments.
NBC News and Kaiser Health News, April 6, 2024: NBC News reported the Kaiser Health News investigation showing that 10 doctors who advised FDA about Abbott’s heart device TriClip had financial ties to the company that weren’t disclosed. Their votes almost unanimously supported approval. We explain that FDA conflict of interest rules are too loose.
Read More »Scientists urge FDA to rescind approval of test for opioid addiction risk
Washington Post, April 5, 2024: NCHR president is one of 31 scientists urging FDA to rescind approval of AvertD DNA test that purports to predict risk of opioid addiction and urging CMS to refuse to pay for the test because it does not work and can do more harm than good.
Read More »OTC Birth Control Pill Headed to US Pharmacies: What Your Patients Should Know
Medscape March 14, 2024: What patients should know about OTC birth control pill Opill, which will be available in March 2024. How can we make sure patients know the risks and use it correctly and we point out that patients shouldn’t assume that just because it doesn’t require a prescription doesn’t mean it doesn’t have risks.
Read More »